1. Home
  2. JBDI vs SCNX Comparison

JBDI vs SCNX Comparison

Compare JBDI & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBDI
  • SCNX
  • Stock Information
  • Founded
  • JBDI 1983
  • SCNX 2010
  • Country
  • JBDI Singapore
  • SCNX United States
  • Employees
  • JBDI N/A
  • SCNX N/A
  • Industry
  • JBDI
  • SCNX Other Pharmaceuticals
  • Sector
  • JBDI
  • SCNX Health Care
  • Exchange
  • JBDI Nasdaq
  • SCNX Nasdaq
  • Market Cap
  • JBDI 28.7M
  • SCNX 31.5M
  • IPO Year
  • JBDI 2024
  • SCNX 2020
  • Fundamental
  • Price
  • JBDI $1.02
  • SCNX $0.67
  • Analyst Decision
  • JBDI
  • SCNX
  • Analyst Count
  • JBDI 0
  • SCNX 0
  • Target Price
  • JBDI N/A
  • SCNX N/A
  • AVG Volume (30 Days)
  • JBDI 59.2K
  • SCNX 65.0M
  • Earning Date
  • JBDI 01-01-0001
  • SCNX 11-12-2025
  • Dividend Yield
  • JBDI N/A
  • SCNX N/A
  • EPS Growth
  • JBDI N/A
  • SCNX N/A
  • EPS
  • JBDI N/A
  • SCNX N/A
  • Revenue
  • JBDI $8,445,000.00
  • SCNX $128,202.00
  • Revenue This Year
  • JBDI N/A
  • SCNX N/A
  • Revenue Next Year
  • JBDI N/A
  • SCNX N/A
  • P/E Ratio
  • JBDI N/A
  • SCNX N/A
  • Revenue Growth
  • JBDI N/A
  • SCNX N/A
  • 52 Week Low
  • JBDI $0.49
  • SCNX $0.46
  • 52 Week High
  • JBDI $3.00
  • SCNX $8.72
  • Technical
  • Relative Strength Index (RSI)
  • JBDI 33.91
  • SCNX 44.94
  • Support Level
  • JBDI $1.11
  • SCNX $0.65
  • Resistance Level
  • JBDI $1.23
  • SCNX $0.78
  • Average True Range (ATR)
  • JBDI 0.12
  • SCNX 0.16
  • MACD
  • JBDI -0.03
  • SCNX -0.02
  • Stochastic Oscillator
  • JBDI 4.54
  • SCNX 1.08

About JBDI JBDI Holdings Limited Ordinary Shares

JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: